Ceylon Hospitals Plc

CHL.N0000Moderately undervalued

Healthcare · Hospital/Nursing Management

Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services.

CHL shares are down 7.6% over the past year and last closed at Rs 64.90 on Nov 17, 2026.

Voting
Rs 64.90
-0.15%
as of Nov 17, 2026
Price history
-7.62%
P/E
11.4to Mar 26
P/B
0.88
NAV / Share
Rs 73.57
EPS
Rs 5.68to Mar 26
Profit Growth
-2.2%
Div Yield
1.69%
Market Cap
Rs 10.4B
Beta
1.03
ROE
8.7%
Op Margin
14.9% (+1.4pp)

Fundamentals

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue
Rs 11.0B
+12.6%
Rs 9.8B
+6.5%
Rs 9.2B
+15.8%
Rs 7.9B
+0.8%
Rs 7.8B
+41.4%
Rs 5.5B
-7.2%
Rs 6.0B
+2.9%
Rs 5.8B
+1.3%
Operating profit
Rs 1.6B
+34.5%
Rs 1.2B
+64.6%
Rs 703.9M
-25.2%
Rs 941.0M
-30.9%
Rs 1.4B
+112.8%
Rs 639.8M
-0.7%
Rs 644.6M
+3.5%
Rs 622.9M
-5.5%
Net profit
Rs 1.1B
+44.9%
Rs 726.0M
+60.0%
Rs 453.8M
-30.4%
Rs 651.7M
-41.3%
Rs 1.1B
+84.8%
Rs 600.3M
+28.5%
Rs 467.1M
+24.1%
Rs 376.3M
-22.9%
EPS
5.68
-65.3%
16.38
+41.3%
11.59
-31.3%
16.88
-41.8%
29.00
+75.3%
16.54
+38.9%
11.91
+25.4%
9.50
-20.0%

Compared with the same period a year earlier.

Per-share figures are as reported, not adjusted for splits.

Ex-dateDividendPer share
Jun 1, 2026FY2026 · first interimRs 1.10
Jun 23, 2025FY2025 · first interimRs 4.00
Jun 11, 2024FY2024 · first interimRs 2.00
May 22, 2023FY2023 · first interimRs 2.30
May 30, 2022FY2022 · first interimRs 5.00
May 28, 2021FY2021 · first interimRs 3.20
Aug 28, 2020FY2020 · first and finalRs 2.20
May 21, 2019FY2019 · second interimRs 3.60

Upcoming dividends, rights issues and splits across the CSE: dividend calendar →

Peer comparison5 peers in Healthcare
P/E
6.1
P/B
1.31
ROE
11.69%
Yield
0.00%
P/E
12.2
P/B
1.40
ROE
15.17%
Yield
2.82%
P/E
15.9
P/B
2.46
ROE
16.28%
Yield
0.00%
CHL.N0000 · this company
P/E
11.4
P/B
0.88
ROE
8.71%
Yield
1.69%
P/E
41.0
P/B
7.78
ROE
4.65%
Yield
0.00%
P/E
7.0
P/B
0.83
ROE
11.97%
Yield
0.00%
Peer median · 5 companies
P/E 12.2P/B 1.40Yield 0.00%

About Ceylon Hospitals Plc

Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services. The Group's narrative focuses on delivering inpatient, outpatient and day-case care alongside specialised clinical services supported by surgical and diagnostic capabilities. Operations include the main Durdans hospital and an islandwide laboratory and diagnostics network, complemented by education and workforce development through the Amrak Institute of Medical Sciences and related subsidiaries. Named subsidiaries in the Group scope include Durdans Medical & Surgical Hospital (Pvt) Ltd, Amrak Institute of Medical Sciences (Pvt) Ltd and Ceygen Biotech (Pvt) Ltd. The Group operates across Sri Lanka with its head office in Colombo and has expanded services into regions including Galle and Kurunegala, maintaining standards aligned with international accreditation and pursuing digital and service expansion initiatives.

AI analysis

bullish

Evidence points bullish: September profit grew 44.1% as operating margin widened, reinforcing a moderately undervalued starting point. The catch is that the share is more expensive than its own history on both P/E and P/B.

Read the full report (Nov 13, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Not enough news to read

1 article in 30 days: 0 positive, 0 negative, 1 neutral.

24 months positive negative 3-month net
Jan 25: 4 articles, net +0.25Jun 25: 1 articles, net +1.00May 26: 1 articles, net +1.00Nov 24Mar 25Jul 25Nov 25Mar 26Jul 26
Recent news
View all news →
EconomyNext·Oct 21, 2026·Market commentary
Sri Lanka stocks close down; ASPI sheds 0.28-pct

Colombo Stock Exchange closed lower: ASPI fell 0.28% (down 56.48 pts) to 19,927.30 and the S&P SL20 fell 0.43% to 5,656.91. Market turnover was LKR 1.5 billion; top gainers included Distilleries, PGP Glass, Singer and Asiri, while Carson Cumberbatch, Bukit Darah, JKH, Hayleys and Commercial Bank led decliners.

EconomyNext·Oct 19, 2026·M&A / stake change
Dialog cuts controlling stake in Doc990 operator Digital Health to 45-pct

Dialog Axiata reduced its combined stake in Digital Health from 64.66% to 44.66%, selling 16.65% (3,747,132 shares) to Sunshine Healthcare for LKR 312.17m and 3.35% (752,868 shares) to Nawaloka for LKR 62.72m; Digital Health will be reclassified from a subsidiary to an associate. Sunshine now holds 21.92%; Nawaloka 12.12%; Asiri 13.33%.

Healthcare & Pharma
EconomyNext·Oct 19, 2026·M&A / stake change
Sri Lanka's Sunshine Healthcare buys 21.9-pct stake in Doc990

Sunshine Holdings' unit Sunshine Healthcare bought a 21.92% stake in Digital Health (Doc990) for LKR 410.83 million via two share purchase agreements on Oct 16, acquiring 16.65% from Dialog Axiata's subsidiary and 5.26% from Ceylon Hospitals.

Healthcare & PharmaIT & Digital
EconomyNext·Oct 19, 2026·Market commentary
Sri Lanka shares edge lower in early trade

Colombo bourse opened flat with the ASPI down 0.06% at 20,173.56 and market turnover Rs 232.69m (banks led turnover Rs 108.38m). Sunshine Holdings' unit bought ~21.92% of Digital Health for Rs 410.83m; Union Chemicals declared a Rs48 interim dividend (record date Oct 28, pay Nov 13, 2026).

Healthcare & PharmaIT & Digital
Daily FT·Oct 19, 2026·M&A / stake change
Dialog cedes Doc990 control as Sunshine buys 22% for Rs. 375 m

Dialog Axiata sold part of its stake in Digital Health (Doc990), reducing the Dialog Group's holding to 44.66% and causing Digital Health to cease being a Group subsidiary. Sunshine Healthcare paid to become a c.21.92% holder (total outlay Rs.410.8m) while Nawaloka raised its stake to 12.12% and Durdans exited; price was Rs.83.31/share valuing Digital Health at Rs.1.87bn.

Healthcare & PharmaIT & Digital
Daily FT·Jan 10, 2026·Market commentary
CSE ends week with ASPI 3.4% on the up and Rs. 265 b value

Colombo bourse closed the week up 3.45% as the ASPI rose 0.54% yesterday to 23,654.30, with the market gaining about Rs. 264.8 billion in value for the week and daily turnover over Rs. 8.5 billion; top contributors included JKH, COMB, VONE, CARS and NTB.

Consumer Staples (FMCG)
EconomyNext·Jan 7, 2026·Share split / sub-division
Sri Lanka’s Durdans announces share sub division

Ceylon Hospitals (Durdans) will seek shareholder approval to subdivide voting shares from 31,762,723 to 127,050,892 and non-voting shares from 10,133,765 to 40,535,060 (1-for-4); stated capital will remain at 1,778,802,331.50 rupees and the plan is pending regulatory approval.

Healthcare & Pharma
Daily FT·Jan 7, 2026·Share split / sub-division
Durdens Hospital proposes four-for-one share split

Ceylon Hospitals (Durdens) will propose a 4-for-1 subdivision of both ordinary voting and non-voting shares, subject to regulatory and shareholder approvals. Voting shares would rise to 127,050,892 and non-voting to 40,535,060, with stated capital unchanged at Rs. 1,778,802,331.50.

Healthcare & Pharma

Healthcare sector: what is happening

Last 30 days to Nov 18, 2026

Healthcare news centred on public-sector purchasing, with procurement reforms and PROMIS digital monitoring intended to speed medicine purchases, affecting suppliers' order flow and delivery cycles. Cabinet approval to draft amendments to the Ayurveda Act would formalise regulation of indigenous medicine and enable licences for local-medicine exports. ADB-backed social-protection investment also includes eldercare, supporting care-service capacity.

Auto-generated from 11 sector news articles over 30 days. Not investment advice.